Interestingly, while in prostate cancer CFTR was reported to upregulate tumour suppressor miR-193b (which suppresses uPA) [174], in breast cancer CFTR seems to repress uPA by inhibiting NF-κB, a known uPA activator [18]. This evidence concerns the gene PLAU and breast carcinoma.